Literature DB >> 10639284

Design, synthesis, and biological evaluation of matrix metalloproteinase inhibitors derived from a modified proline scaffold.

M Cheng1, B De, N G Almstead, S Pikul, M E Dowty, C R Dietsch, C M Dunaway, F Gu, L C Hsieh, M J Janusz, Y O Taiwo, M G Natchus, T Hudlicky, M Mandel.   

Abstract

The synthesis and structure-activity relationship (SAR) studies of a series of proline-based matrix metalloproteinase inhibitors are described. The data reveal a remarkable potency enhancement in those compounds that contain an sp(2) center at the C-4 carbon of the ring relative to similar, saturated compounds. This effect was noted in compounds that contained a functionalized oxime moiety or an exomethylene at C-4, and the potencies were typically <10 nM for MMP-3 and <100 nM for MMP-1. Comparisons were then made against compounds with similar functionality where the C-4 carbon was reduced to sp(3) hybridization and the effect was typically an order of magnitude loss in potency. A comparison of compounds 14 and 34 exemplifies this observation. An X-ray structure was obtained for a stromelysin-inhibitor complex which provided insights into the SAR and selectivity trends observed within the series. In vitro intestinal permeability data for many compounds was also accumulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10639284     DOI: 10.1021/jm9904699

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

2.  Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.

Authors:  Yonghao Jin; Mark D Roycik; Dale B Bosco; Qiang Cao; Manuel H Constantino; Martin A Schwartz; Qing-Xiang Amy Sang
Journal:  J Med Chem       Date:  2013-05-16       Impact factor: 7.446

3.  A QSAR Study of Matrix Metalloproteinases Type 2 (MMP-2) Inhibitors with Cinnamoyl Pyrrolidine Derivatives.

Authors:  Eduardo Borges de Melo
Journal:  Sci Pharm       Date:  2012-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.